Aimee Landry
AstraZeneca (United States)(US)
Publications by Year
Research Areas
Immune Response and Inflammation, NF-κB Signaling Pathways, Helicobacter pylori-related gastroenterology studies, Immune Cell Function and Interaction, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease(2008)660 cited
- → Erythropoietin regulates endothelial progenitor cells(2003)499 cited
- → The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells(2008)149 cited
- → Ca2+/Calmodulin-Dependent Protein Kinase II Is a Modulator of CARMA1-Mediated NF-κB Activation(2006)100 cited
- → Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer(2021)73 cited
- → Differential requirement for CARMA1 in agonist‐selected T‐cell development(2009)66 cited
- → CARMA3 Mediates Lysophosphatidic Acid–Stimulated Cytokine Secretion by Bronchial Epithelial Cells(2008)45 cited
- → DLGH1 Is a Negative Regulator of T-Lymphocyte Proliferation(2007)37 cited
- → MAST3: a novel IBD risk factor that modulates TLR4 signaling(2008)32 cited
- → Nore1B regulates TCR signaling via Ras and Carma1(2006)14 cited